生物活性
PLX4032(Vemurafenib)也称为RG7204,Vemurafenib,R7204,RO5185426。PLX4032是B-raf抑制剂,IC50为44 nM。
Targets
Target |
Value |
SRMS |
IC50: 18nM |
ACK1 |
IC50: 19nM |
B-Raf(V600E) |
IC50: 31nM |
C-Raf |
IC50: 48nM |
MAP4K5(KHS1) |
IC50: 51nM |
FGR |
IC50: 63nM |
B-Raf |
IC50: 100nM |
LCK |
IC50: 183nM |
BRK |
IC50: 213nM |
NEK11 |
IC50: 317nM |
BLK |
IC50: 547nM |
LynB |
IC50: 599nM |
YES1 |
IC50: 604nM |
WNK3 |
IC50: 877nM |
MNK2 |
IC50: 1.717μM |
FRK(PTK5) |
IC50: 1.884μM |
CSK |
IC50: 2.339μM |
Src |
IC50: 2.389μM |
化学数据
目录号 |
A10739 |
作用机制 |
Inhibitor (抑制剂) |
M. Wt |
489.9 |
Formula |
C23H18ClF2N3O3S |
Purity |
>99% |
Storage |
Store lyophilized at -20?C, keep desiccated. In lyophilized form, the chemical is stable for36 months. In solution, store at -20?C and use within3 monthsto prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles. |
CAS No. |
918504-65-1 |
Synonyms |
RG7204,RO5185426,Zelboraf, PLX-4032 |
SMILES |
CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F |
溶解度
In vitro (25°C) |
DMSO |
83 mg/mL (169.41 mM) |
Water |
Insoluble |
Ethanol |
Insoluble |
In vivo |
4% DMSO+30% PEG 300+5% Tween 80+ddH2O (suspension) |
4 mg/mL |
*<1 mg/ml means slightly soluble or insoluble. *Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
储备液配制
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
0.1 mM |
20.41 mL |
102.06 mL |
204.12 mL |
0.5 mM |
4.08 mL |
20.41 mL |
40.82 mL |
1 mM |
2.04 mL |
10.21 mL |
20.41 mL |
5 mM |
0.41 mL |
2.04 mL |
4.08 mL |
*The above data is based on the productmolecular weight 489.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.